Product logins

Find logins to all Clarivate products below.


Aesthetic Injectables | Market Insights | Latin America (Supplemental) | 2019

The Latin American market for aesthetic injectables will show strong growth through 2027. Although some factors—such as weak currencies and strict regulations in some countries—will  have a negative impact in the short term, high levels of aesthetic consciousness and improving economic conditions in the region will lead to sustained revenue growth over the forecast period.

This Medtech 360 Report provides high-level market metrics for aesthetic injectables in Latin America, including country-level data for major countries and aggregate data for the rest of Latin America, across a 10-year period

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Latin America
The Latin American interventional oncology device market will see moderate growth through 2034, driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Urological Devices – Market Insights – Latin America
The Latin American urological device market will continue to expand through 2034, driven by the rising prevalence of kidney stones and UI, aging populations, and growing patient awareness of…
Report
Trauma Devices – Market Insights – Latin America
The Latin American trauma device market is positioned for strong growth, driven by the rapid expansion of highvolume product segments, a growing aging population, and increasingly favorable…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Latin America (Supplemental) | 2023
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…